Lucyd, Inc (LUCYW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 14Jul 17Jul 22Jul 27Jul 30Aug 4Aug 7Aug 12

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.4x

Market Cap

$296095.58

MomentumView details →

1D Return

+5.09%

YTD Return

+2.17%

RSI (14)

44.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.4x

Market Cap

$296095.58

RSI (14)

44.9

MomentumView details →

1D Return

+5.09%

YTD Return

+2.17%

ProfitabilityView details →

Gross Margin

22.79%

Net Margin

−225.28%

EBITDA Margin

−222.76%

ROE (TTM)

−111.42%

ROA (TTM)

−102.86%

Asset Turnover

0.40x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+59.19%

EPS CAGR 3Y

+63.39%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.26

EPS Surprise

29.73%

Beats (12Q)

1/12

Next Q EPS Est

−$0.35

Avg Surprise (4Q)

29.73%

Rev Surprise

12.28%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

12.06x

Quick Ratio

11.25x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

3.41M

Net Income (TTM)

−7.69M

Op. CF (TTM)

−7.20M

Next earningsNov 12, 2026 →

Latest newsMore news →

No recent news for LUCYW.

Similar companies

NEXGEL, Inc.NXGLW GlucoTrack, Inc.GCTK Meihua International Medical Technologies Co., Ltd.MHUA NEXGEL, Inc.NXGL Predictive Oncology Inc.POAI WORK Medical Technology Group Ltd.WOK Find similar companies →

Latest newsMore news →

No recent news for LUCYW.